These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 18564398)

  • 61. A pilot study to assess the hemostatic function of pathogen-reduced platelets in patients with thrombocytopenia.
    Johansson PI; Simonsen AC; Brown PN; Ostrowski SR; Deberdt L; Van Hoydonck P; Yonemura SS; Goodrich RP
    Transfusion; 2013 Sep; 53(9):2043-52. PubMed ID: 23278371
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Association of red blood cell and platelet allo-antibodies in platelet alloimmunized patients].
    Moncharmont P; Rigal D
    Transfus Clin Biol; 2014 Jun; 21(3):99-102. PubMed ID: 24948207
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution.
    Balbuena-Merle R; West FB; Tormey CA; Hendrickson JE
    Transfusion; 2019 Jun; 59(6):1911-1915. PubMed ID: 30865314
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Severe thrombocytopenia in a child secondary to passive platelet antibody transfer from a plasma transfusion.
    Collins CL; Scott JP; Panepinto JA; Punzalan RC
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):e226-8. PubMed ID: 23459377
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
    Wong M; Narra R; Selim M; Zimmerman MA; Kim J; Padmanabhan A; Hong JC
    J Surg Res; 2020 Nov; 255():99-105. PubMed ID: 32543385
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thrombocytopenia caused by passive transfusion of anti-glycoprotein Ia/IIa alloantibody (anti-HPA-5b).
    Warkentin TE; Smith JW; Hayward CP; Ali AM; Kelton JG
    Blood; 1992 May; 79(9):2480-4. PubMed ID: 1571561
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report.
    Jacquot C; Moayeri M; Kim B; Shugarts S; Lynch KL; Leavitt AD
    Transfusion; 2013 Nov; 53(11):2715-21. PubMed ID: 23451879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methods for the selection of platelet products for alloimmune-refractory patients.
    Kopko PM; Warner P; Kresie L; Pancoska C
    Transfusion; 2015 Feb; 55(2):235-44. PubMed ID: 25393955
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Posttransfusion platelet increments after different platelet products in neonates: a retrospective cohort study.
    Honohan A; van't Ende E; Hulzebos C; Lopriore E; van't Verlaat E; Govaert P; Brand A; van der Bom J
    Transfusion; 2013 Dec; 53(12):3100-9. PubMed ID: 23441721
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A simple and rapid competitive enzyme-linked immunosorbent assay to identify HPA-1a (PlA1)-negative donor platelet units.
    Denomme G; Horsewood P; Xu W; Smith J; Kelton J
    Transfusion; 1996 Sep; 36(9):805-8. PubMed ID: 8823455
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preoperative use of platelets in a 6-year-old with acute appendicitis and a myosin heavy chain 9-related disorder: a case report and review of literature.
    Eichel Y; Tormos LM; Squires JE
    Transfusion; 2016 Feb; 56(2):349-53. PubMed ID: 26446054
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sulfamethoxazole-induced thrombocytopenia masquerading as posttransfusion purpura: a case report.
    Nixon CP; Cheves TA; Sweeney JD
    Transfusion; 2015 Nov; 55(11):2738-41. PubMed ID: 26098194
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Posttransfusion purpura-like syndrome associated with CD36 (Naka) isoimmunization.
    Bierling P; Godeau B; Fromont P; Bettaieb A; Debili N; el-Kassar N; Rouby JJ; Vainchenker W; Duedari N
    Transfusion; 1995 Sep; 35(9):777-82. PubMed ID: 7570941
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion.
    Peña JR; Saidman SL; Girouard TC; Meister E; Dzik WH; Makar RS
    Am J Hematol; 2014 Sep; 89(9):E133-7. PubMed ID: 24816643
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immature platelets do not reliably predict platelet recovery in patients with intensive chemotherapy or stem cell transplantation.
    Meintker L; Fritsch JD; Ringwald J; Krause SW
    Vox Sang; 2017 Feb; 112(2):132-139. PubMed ID: 28120415
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evidence-based platelet transfusion guidelines.
    Slichter SJ
    Hematology Am Soc Hematol Educ Program; 2007; ():172-8. PubMed ID: 18024626
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Management of bleeding in a multi-transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of cross-matched platelets.
    Heuer L; Blumenberg D
    Blood Coagul Fibrinolysis; 2005 Jun; 16(4):287-90. PubMed ID: 15870549
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma-clotting proteins.
    Valeri CR; Khuri S; Ragno G
    Transfusion; 2007 Oct; 47(4 Suppl):206S-248S. PubMed ID: 17888061
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Successful use of rituximab in platelet transfusion refractoriness in a multi-transfused patient with myelodysplastic syndrome.
    Yu QH; Shen YP; Ye BD; Zhou YH
    Platelets; 2015; 26(2):195-6. PubMed ID: 23634876
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Post-transfusion purpura in a patient with HPA-1a and GPIa/IIa antibodies.
    Woelke C; Eichler P; Washington G; Flesch BK
    Transfus Med; 2006 Feb; 16(1):69-72. PubMed ID: 16480442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.